This is the 7th announcement of 2024 on generic drugs of the Drug Administration of Vietnam.
Up to now, after 7 times of announcing the list of new and renewed generic drugs by the Drug Administration, hundreds of generic drugs have been circulated and used to serve the medical examination and treatment needs of the people, as well as the bidding and procurement of drugs by medical facilities.
Among the 54 branded drugs just announced by the Drug Administration of Vietnam this time, most of the branded drugs originate from countries with large medical and pharmaceutical production systems in the world such as the US, Switzerland, France, UK, Sweden, Greece, the Netherlands, Spain, Japan...
Previously, in October 2024, the Drug Administration of Vietnam twice announced decisions to extend and re-issue circulation registration certificates for nearly 1,300 domestically and internationally produced drugs and pharmaceutical ingredients.
This new issuance and extension aims to ensure meeting the demand for medicine use in medical examination and treatment, epidemic prevention as well as drug bidding and procurement.
It is known that the original brand-name drugs announced by the Ministry of Health in recent times are quite diverse in terms of pharmacological effects, including drugs for treating cancer, cardiovascular disease, hypertension, diabetes, antiviral drugs, drugs for treating respiratory diseases, treating osteoarthritis... There are products in the form of film-coated tablets, external solutions, hard capsules, powdered drugs for suspension, and dispersible tablets.
In the project to amend and supplement a number of articles of the Law on Pharmacy, which is being submitted to the National Assembly for discussion and approval at this session, the Ministry of Health has proposed many policies to promote the production of drugs and raw materials as well as attract foreign investment in the pharmaceutical sector in the direction of: Stipulating preferential/special preferential investment contents for the production of new drugs, original brand-name drugs, herbal drugs and traditional drugs produced from available domestic medicinal materials, drugs applying high technology in production, biotechnology drugs, specialized drugs with technology transfer for production in Vietnam...
